CHI3L1 and cancer: CHI3L1 signaling via these receptors is often activated in distinct combinations depending on cell type and pathological context, and it serves as a key regulatory molecule in fibrosis, allergic inflammation, autoimmune diseases, and cancer [37,38,39,40,41].